SEC 13F Intelligence

Assenagon Asset Management S.A. / EW

Assenagon Asset Management S.A.’s Edwards Lifesciences Corp Position

Does Assenagon Asset Management S.A. own Edwards Lifesciences Corp (EW)? Yes — 1.81M shares worth $164M (+0.20% of its 13F portfolio) as of Q2 2026, up from 1.27M shares the prior filed quarter.

Position Value
$164M
Q2 2026
Shares
1.81M
% of Portfolio
+0.20%
Quarters Held
28
currently held

Position History EW

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q2 ’19: $41MQ3 ’19: $2MQ4 ’19: $255,000Q1 ’20: $17MQ1 ’20Q2 ’20: $910,000Q3 ’20: $909,000Q2 ’21: $218,000Q3 ’21: $896,000Q3 ’21Q4 ’21: $3MQ1 ’22: $3MQ2 ’22: $2MQ3 ’22: $8MQ3 ’22Q4 ’22: $63MQ1 ’23: $72MQ2 ’23: $26MQ3 ’23: $24MQ3 ’23Q4 ’23: $92MQ1 ’24: $85MQ2 ’24: $61MQ3 ’24: $49MQ3 ’24Q4 ’24: $314MQ1 ’25: $298MQ2 ’25: $195MQ3 ’25: $127MQ3 ’25Q4 ’25: $195MQ1 ’26: $101MQ2 ’26: $164Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20261.81M$164M+0.20%
Q1 20261.27M$101M+0.15%
Q4 20252.29M$195M+0.27%
Q3 20251.64M$127M+0.17%
Q2 20252.49M$195M+0.29%
Q1 20254.11M$298M+0.50%
Q4 20244.24M$314M+0.51%
Q3 2024737.1K$49M+0.09%
Q2 2024655.6K$61M+0.13%
Q1 2024886.4K$85M+0.20%
Q4 20231.21M$92M+0.24%
Q3 2023342.1K$24M+0.07%
Q2 2023271.1K$26M+0.09%
Q1 2023866.3K$72M+0.25%
Q4 2022850.0K$63M+0.23%
Q3 202291.3K$8M+0.03%
Q2 202226.2K$2M+0.01%
Q1 202223.8K$3M+0.01%
Q4 202123.0K$3M+0.01%
Q3 20217.9K$896,0000.00%
Q2 20212.1K$218,0000.00%
Q3 202011.4K$909,000+0.01%
Q2 202013.2K$910,000+0.01%
Q1 202088.5K$17M+0.13%
Q4 20191.1K$255,0000.00%
Q3 20199.9K$2M+0.01%
Q2 2019219.6K$41M+0.30%
Q4 201817.4K$3M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of EW.